Huixin Bio
Series A in 2025
Huixin Bio is a researcher and developer of liquid biopsy diagnostic products. It focuses on developing world-leading biomedical technologies and products. It offers an automatic exosome purification system.
Degron Therapeutics
Series A in 2025
Degron Therapeutics is a drug discovery company focused on developing a new class of therapeutics centered around targeted protein degradation. The company specializes in molecular glue degrader drugs, which are small molecules designed to selectively target and degrade specific proteins associated with various diseases. Degron Therapeutics aims to lead the field of small molecule molecular glue degrader medicines by leveraging its expertise to identify and validate challenging disease targets that traditional small molecule inhibitors cannot effectively address. The company is committed to addressing unmet medical needs across a broad range of therapeutic areas by developing innovative protein degradation drugs, utilizing its advanced molecular glue platform technology to enhance treatment efficacy.
Chazhongxi
Seed Round in 2023
Chazhongxi is a tea brand operator whose primary activities include purchasing, processing, and developing new tea formulas.
Niu Yuanwai Handmade Dumplings
Seed Round in 2023
Niu Yuanwai Handmade Dumplings is a handmade dumpling brand operator.
Hetian Shuipu Health Tea
Seed Round in 2023
Hetian Shuipu Health Tea is a producer of traditional herbal tea. They offer healthy tea drinks containing medical ingredients, allowing clients to enjoy a healthy tea drink.
RainSure Scientific
Series C in 2022
RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.
Digital Precision Medical (DPM)
Series B in 2022
DPM Digital Precision Medicine specializes in the development of advanced medical equipment and innovative technology, particularly in the field of intraoperative molecular imaging. The company focuses on creating high-sensitivity and high-definition imaging solutions that enhance surgical navigation during procedures. By prioritizing research and development, DPM Digital Precision Medicine aims to deliver easy-to-operate imaging products that improve the precision and effectiveness of surgical interventions, catering to the needs of medical professionals.
Alit Life Sciences
Series A in 2022
Alit Life Sciences is a supplier of advanced instruments, equipment, and technical services for the life sciences and biotechnology sectors. Established with a focus on delivering comprehensive solutions, the company has developed a range of products, including the Countstar IC1000 cell analyzer launched in 2011, along with various series such as Biotech, Altair, Rigel, and Mira. Alit provides an extensive array of laboratory instruments, testing reagents, and production equipment, supporting clients from research and development through to production. Additionally, the company acts as a supplier of overseas biological equipment, ensuring that customers have access to a complete set of supplies necessary for their operations in the biotech and life sciences industries.
Baicare
Venture Round in 2022
Baicare is a biotechnology company focused on enhancing clinical microbiological testing and promoting the rational use of antibiotics. Utilizing microfluidic chips and gene detection technology, Baicare develops intelligent automated nucleic acid detection products for clinical hospitals. Their innovative chips can rapidly and accurately identify pathogenic bacteria and assess drug resistance, thereby enabling healthcare providers to formulate effective treatment plans. This approach not only alleviates patient suffering but also aims to significantly reduce healthcare costs. The company has experienced rapid growth, securing substantial financial support, including recognition as a "National High-Tech Enterprise." Baicare has filed for over 20 related patents and has garnered attention from both medical experts and investors, underscoring its commitment to improving diagnostics for infectious and genetic diseases.
KingstronBio
Series C in 2021
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.
Help Therapeutics
Series C in 2021
Help Therapeutics, established in 2016, is a global clinical-stage biopharmaceutical company focused on developing first-in-class therapeutics derived from induced pluripotent stem cells (iPSCs) for patients with degenerative diseases. The company aims to create an off-the-shelf cell therapy product pipeline, initially targeting cardiac failure and other related conditions. Help Therapeutics' mission is to deliver safe and effective regenerative treatments by leveraging superior development and manufacturing technologies throughout the therapeutic journey.
Kunya Medical
Series A in 2016
Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.